Cyclopropane

Cyclopropane

SCHEMBL593603

C1CC1.CBr

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromomethane SCHEMBL15110746 1.00
Cyclooctane SCHEMBL11365215 1.00
Cyclohexane SCHEMBL4175245 1.00
Cyclopropane SCHEMBL7188678 0.73
Cyclopentane SCHEMBL12475482 0.73
Cyclohexane SCHEMBL12475590 0.73
Ethane SCHEMBL9395318 0.73
Cyclooctane SCHEMBL8564806 0.73
SCHEMBL25378505 0.71 ALDH1A1 (0.33)
Cyclooctane SCHEMBL11038481 0.71 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452199-B Preparation method of feloxicib 山东鲁抗舍里乐药业有限公司 2021-03-30 CN claimed
CN-101570539-A Morphinone quaternary ammonium salt derivatives and preparation method thereof YOUMAO QI (CN) 2009-11-04 CN claimed
CN-101386604-A Aromatic nitrile-base thiazole derivatives for inhibiting xanthine oxidase activity, preparation method and application YOUMAO QI (CN) 2009-03-18 CN claimed
CN-110452199-B Preparation method of feloxicib 山东鲁抗舍里乐药业有限公司 2021-03-30 CN disclosed
CN-111417638-A Method of producing a composite material 庄信万丰股份有限公司 2020-07-14 CN disclosed
WO-2019161803-A1 PEPTIDYLARGININE DEIMINASE INHIBITOR AND USE THEREOF 南京药捷安康生物科技有限公司 2019-08-29 WO disclosed
WO-2014125408-A2 SUBSTITUTED 1H-PYRROLOPYRIDINONE DERIVATIVES AS KINASE INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2014-08-21 WO disclosed
EP-1804794-B1 SPIROPIPERIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHERMER S DISEASE MERCK SHARP & DOHME (US) 2013-07-31 EP disclosed
CN-101448397-B Selective benzylamine derivatives and their use as cholesteryl ester transfer protein inhibitors REDDYS LAB LTD DR 2013-04-24 CN disclosed
US-8114887-B2 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme Corp. (US) 2012-02-14 US disclosed
CN-100595204-C Bisaminated phosphonate prodrugs METABASIS THERAPEUTICS INC 2010-03-24 CN disclosed
EP-1804794-A2 SPIROPIPERIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHERMER S DISEASE Merck & Co., Inc. (US) 2007-07-11 EP disclosed
CN-1900087-A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase METABASIS THERAPEUTICS INC (US) 2007-01-24 CN disclosed
WO-2006044497-A2 SPIROPIPERIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHERMER’S DISEASE MERCK & CO., INC. (US) 2006-04-27 WO disclosed
CN-1740182-A Novel bisamidate phosphonate prodrugs METABASIS THERAPEUTICS INC (US) 2006-03-01 CN disclosed
CN-1704423-A Novel heteroaromatic inhibitors of fructose-1, 6-bisphosphatase METABASIS THERAPEUTICS INC (US) 2005-12-07 CN disclosed
CN-1215076-C Novel heteroaromatic inhibitors of fructose-1, 6-bisphosphatase METABASIS THERAPEUTICS INC (US) 2005-08-17 CN disclosed
CN-1599612-A Combination of FBP enzyme inhibitor and antidiabetic agent for treating diabetes METABASIS THERAPEUTICS INC (US) 2005-03-23 CN disclosed
CN-1434828-A Novel bisaminophosphonate prodrugs METABASIS THERAPEUTICS INC (US) 2003-08-06 CN disclosed
CN-1326459-A Novel heteroaromatic inhibitors of fructose-1, 6-bisphosphatase METABASIS THERAPEUTICS INC (US) 2001-12-12 CN disclosed